Tweet
<img alt="" height="1" width="1" />
FDA will take extra 3 months on Cumberland drug
BusinessWeek
Cumberland Pharmaceuticals Inc. said Friday the Food and Drug Administration extended its review of Acetadote as a treatment for patients with non-acetaminophen acute liver failure. The review was extended three months, with a potential decision date ...
FDA Extends Review Of Cumberland's Acetadote; Shares DropWall Street Journal
Cumberland says FDA extends liver drug review dateReuters
Cumberland Pharma Announces 3 Months Extension Of FDA Review Of Acetadote ...RTT News
PR Newswire (press release) -Seeking Alpha (blog)
all 29 news articles »
More...